Anthony Krizman

Anthony Krizman appears in our data through filings on Sagent Pharmaceuticals, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 22 February 2013 to 29 August 2016, the count stands at 12 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The newest entry dates from 31 August 2016: a transaction of €138k, in Sagent Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.